Screener
Bio-Techne TECH Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056302
| Line item | March 31, 2026 / (unaudited) | June 30, 2025 |
|---|---|---|
| Total assets | $2,550,601 | $2,557,868 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Trade accounts payable | $23,490 | $25,311 |
| Salaries, wages and related accruals | 54,429 | 65,791 |
| Accrued expenses | 17,682 | 25,663 |
| Contract liabilities | 38,433 | 32,571 |
| Income taxes payable | 2,971 | 10,770 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Bio-Techne's accounts payable?
- Bio-Techne (TECH) reported accounts payable of $23.49M in Q1 2026.
- How has Bio-Techne's accounts payable changed year-over-year?
- Bio-Techne's accounts payable decreased by 25.8% year-over-year, from $31.64M to $23.49M.
- What is the long-term trend for Bio-Techne's accounts payable?
- Over 4 years (2021 to 2025), Bio-Techne's accounts payable has grown at a -3.7% compound annual growth rate (CAGR), from $29.38M to $25.31M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Bio-Techne's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude